Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors.

CRP and IL-6 Kyn/Trp Phe/Tyr frailty modifiable risk factors neopterin nitrite oxi-immune markers oxidative DNA damage vitamin A and vitamin E

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
10 Dec 2021
Historique:
received: 11 10 2021
revised: 22 11 2021
accepted: 02 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 25 12 2021
Statut: epublish

Résumé

Ageing is accompanied with a decline in several physiological systems. Frailty is an age-related syndrome correlated to the loss of homeostasis and increased vulnerability to stressors, which is associated with increase in the risk of disability, comorbidity, hospitalisation, and death in older adults. The aim of this study was to understand the relationship between frailty syndrome, immune activation, and oxidative stress. Serum concentrations of vitamins A and E were also evaluated, as well as inflammatory biomarkers (CRP and IL-6) and oxidative DNA levels. A group of Portuguese older adults (≥65 years old) was engaged in this study and classified according to Fried's frailty phenotype. Significant increases in the inflammatory mediators (CRP and IL-6), neopterin levels, kynurenine to tryptophan ratio (Kyn/Trp), and phenylalanine to tyrosine ratio (Phe/Tyr), and significant decreases in Trp and Tyr concentrations were observed in the presence of frailty. IL-6, neopterin, and Kyn/Trp showed potential as predictable biomarkers of frailty syndrome. Several clinical parameters such as nutrition, dependency scales, and polypharmacy were related to frailty and, consequently, may influence the associations observed. Results obtained show a progressive immune activation and production of pro-inflammatory molecules in the presence of frailty, agreeing with the inflammageing model. Future research should include different dimensions of frailty, including psychological, social, biological, and environmental factors.

Identifiants

pubmed: 34943076
pii: antiox10121975
doi: 10.3390/antiox10121975
pmc: PMC8750623
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/121802/2016
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BPD/115112/2016
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BPD/100948/2014
Organisme : Ministerio de Ciencia e Innovación
ID : PID2020-113788RB-I00
Organisme : Ministerio de Educación Cultura y Deporte
ID : BEAGAL18/00142

Références

Arch Gerontol Geriatr. 2018 Jan;74:162-168
pubmed: 29112877
Clin Exp Immunol. 2013 Jul;173(1):121-30
pubmed: 23607723
Mech Ageing Dev. 2012 Jun;133(6):456-66
pubmed: 22663935
J Epidemiol Community Health. 2014 Aug;68(8):703-4
pubmed: 24782415
Clin Geriatr Med. 2011 Feb;27(1):27-37
pubmed: 21093720
J Am Geriatr Soc. 2012 Aug;60(8):1487-92
pubmed: 22881367
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
Aging Cell. 2012 Oct;11(5):912-5
pubmed: 22708923
Lancet. 1999 Jan 16;353(9148):205-6
pubmed: 9923878
Metabolism. 2017 Mar;68:64-76
pubmed: 28183454
Int Psychogeriatr. 2018 Jan;30(1):115-124
pubmed: 28931449
Exp Gerontol. 2020 Mar 3;134:110895
pubmed: 32151793
Geriatr Gerontol Int. 2015 Aug;15(8):951-60
pubmed: 25255891
Toxicol Lett. 2020 May 5;330:14-22
pubmed: 32380123
J Am Geriatr Soc. 2009 Sep;57(9):1666-71
pubmed: 19682113
Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):637-46
pubmed: 25858336
J Am Geriatr Soc. 2017 Feb;65(2):e27-e32
pubmed: 28024089
J Am Geriatr Soc. 2019 Dec;67(12):2482-2489
pubmed: 31648378
Exp Gerontol. 2009 Nov;44(11):740-4
pubmed: 19723576
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Nat Rev Cardiol. 2018 Sep;15(9):505-522
pubmed: 30065258
Rev Esp Salud Publica. 2012 Oct;86(5):495-508
pubmed: 23223762
Maturitas. 2017 Jan;95:31-35
pubmed: 27889050
Br J Clin Pharmacol. 2018 Jul;84(7):1432-1444
pubmed: 29575094
Ageing Res Rev. 2019 Sep;54:100935
pubmed: 31326616
Eur J Intern Med. 2016 Jun;31:3-10
pubmed: 27039014
Am J Clin Nutr. 2016 Jul;104(1):132-42
pubmed: 27194305
Eur J Clin Pharmacol. 2019 Apr;75(4):451-466
pubmed: 30610276
J Nutr Health Aging. 2014 Mar;18(3):264-9
pubmed: 24626753
Med J Aust. 2020 Mar;212(4):183-188
pubmed: 31886526
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):278-83
pubmed: 16567378
J Am Med Dir Assoc. 2017 Dec 1;18(12):1049-1057
pubmed: 28801236
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Am Med Dir Assoc. 2017 Feb 1;18(2):169-175
pubmed: 27847264
J Gerontol A Biol Sci Med Sci. 2010 Apr;65(4):407-13
pubmed: 19933749
Clin Biochem. 2013 Dec;46(18):1848-51
pubmed: 24183885
Arch Toxicol. 2013 Jun;87(6):949-68
pubmed: 23685795
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
Immun Ageing. 2016 Jun 03;13:21
pubmed: 27274758
J Am Med Dir Assoc. 2018 Jan;19(1):77-82
pubmed: 28943182
Mech Ageing Dev. 2020 Apr;187:111217
pubmed: 32088282
Clin Chem. 2002 Mar;48(3):579-81
pubmed: 11861457
Front Immunol. 2018 May 16;9:1056
pubmed: 29868017
J Am Med Dir Assoc. 2015 Mar;16(3):253-7
pubmed: 25548029
J Gerontol A Biol Sci Med Sci. 2017 Sep 1;72(9):1277-1283
pubmed: 26975982
Aging (Albany NY). 2020 Nov 13;12(21):22253-22265
pubmed: 33188590
J Acquir Immune Defic Syndr (1988). 1990;3(9):873-6
pubmed: 2166783
Exp Gerontol. 2020 May;133:110858
pubmed: 32007546
Geriatr Gerontol Int. 2017 Jun;17(6):913-918
pubmed: 27296166
Arch Intern Med. 2002 Nov 11;162(20):2333-41
pubmed: 12418947
Arch Gerontol Geriatr. 2017 Nov;73:187-194
pubmed: 28822920
J Gerontol A Biol Sci Med Sci. 2019 Jan 16;74(2):168-175
pubmed: 29684114
Gerontology. 2015;61(5):407-15
pubmed: 25924722
Exp Gerontol. 2018 Oct 2;112:119-126
pubmed: 30240849
Med Hypotheses. 2011 Mar;76(3):317-21
pubmed: 20961694
Ageing Res Rev. 2016 Nov;31:1-8
pubmed: 27592340
Aging Clin Exp Res. 2008 Apr;20(2):91-102
pubmed: 18431075
Aging (Albany NY). 2020 May 27;12(10):9982-9999
pubmed: 32461379
Geroscience. 2020 Dec;42(6):1451-1473
pubmed: 32803650
Am J Med. 1999 May;106(5):506-12
pubmed: 10335721
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Cochrane Database Syst Rev. 2013 Jun 05;(6):CD001507
pubmed: 23737086
Front Psychol. 2020 Mar 26;11:434
pubmed: 32273861
Immunol Lett. 1991 Jun;28(3):207-11
pubmed: 1909303
Altern Med Rev. 2000 Feb;5(1):64-71
pubmed: 10696120
Curr Pharm Des. 2009;15(26):3003-26
pubmed: 19754376
Clin Geriatr Med. 2011 Feb;27(1):1-15
pubmed: 21093718
J Nutr Health Aging. 2009 Nov;13(9):782-8
pubmed: 19812868
J Toxicol Environ Health A. 2019;82(14):815-825
pubmed: 31405343
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9090-5
pubmed: 12840146
Clin Interv Aging. 2006;1(1):81-91
pubmed: 18047260
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):819-27
pubmed: 19822098
Ageing Res Rev. 2017 Aug;37:1-15
pubmed: 28487242
Vaccine. 2000 Feb 25;18(16):1717-20
pubmed: 10689155
Mech Ageing Dev. 2007 Jan;128(1):92-105
pubmed: 17116321
Expert Rev Clin Pharmacol. 2020 Nov;13(11):1179-1181
pubmed: 32985932
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):864-872
pubmed: 29346525
Am J Med Sci. 2012 Nov;344(5):395-8
pubmed: 22739566
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Free Radic Biol Med. 2009 Oct 1;47(7):983-91
pubmed: 19596065
Disabil Rehabil. 2017 Sep;39(19):1897-1908
pubmed: 27558741
Toxicology. 2008 Oct 30;252(1-3):40-8
pubmed: 18721846
J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7):M448-53
pubmed: 11445604
J Nutr Health Aging. 2011 Nov;15(9):756-60
pubmed: 22089224
J Clin Pathol. 2009 Jan;62(1):1-5
pubmed: 18818262
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109703
pubmed: 31325470
Atherosclerosis. 2009 Feb;202(2):543-9
pubmed: 18556000
BMC Geriatr. 2011 Jul 01;11:33
pubmed: 21722355
Neuroimmunomodulation. 2010;17(3):202-4
pubmed: 20134203
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95
pubmed: 33328614
JAMA. 2001 Jul 18;286(3):327-34
pubmed: 11466099
J Clin Endocrinol Metab. 2013 Jan;98(1):31-42
pubmed: 23185034
Ageing Res Rev. 2018 Nov;47:214-277
pubmed: 30071357
Neuropsychobiology. 2020;79(1):89-99
pubmed: 30808841

Auteurs

Armanda Teixeira-Gomes (A)

EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Environmental Health Department, National Institute of Health Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), Rua das Taipas 135, 4050-600 Porto, Portugal.

Blanca Laffon (B)

Centro de Investigaciones Científicas Avanzadas (CICA), Grupo DICOMOSA, Departamento de Psicología, Facultad de Ciencias de la Educación, Campus Elviña s/n, Universidade da Coruña, 15071 A Coruña, Spain.
Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC. Oza, 15071 A Coruña, Spain.

Vanessa Valdiglesias (V)

Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC. Oza, 15071 A Coruña, Spain.
Centro de Investigaciones Científicas Avanzadas (CICA), Grupo NanoToxGen, Departamento de Biología, Facultad de Ciencias, Campus A Zapateira s/n, Universidade da Coruña, 15071 A Coruña, Spain.

Johanna M Gostner (JM)

Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Thomas Felder (T)

Department of Laboratory Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.

Carla Costa (C)

EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Environmental Health Department, National Institute of Health Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), Rua das Taipas 135, 4050-600 Porto, Portugal.

Joana Madureira (J)

EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Environmental Health Department, National Institute of Health Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), Rua das Taipas 135, 4050-600 Porto, Portugal.

Dietmar Fuchs (D)

Institute of Biological Chemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.

João Paulo Teixeira (JP)

EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Environmental Health Department, National Institute of Health Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), Rua das Taipas 135, 4050-600 Porto, Portugal.

Solange Costa (S)

EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Environmental Health Department, National Institute of Health Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), Rua das Taipas 135, 4050-600 Porto, Portugal.

Classifications MeSH